Meeker David P
SEC-identified person · CIK 1385155 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kardigan, Inc. KARD | Director | filed 2026 - 2026 |
| Trevi Therapeutics, Inc. TRVI | Director | filed 2019 - 2026 |
| Pharvaris N.V. PHVS | Director | filed 2026 - 2026 |
| Rhythm Pharmaceuticals, INC. SRYTM | Director · President and CEO | filed 2017 - 2026 |
| Myokardia, Inc. MYOK | Director | filed 2017 - 2020 |
| Turmeric Acquisition Corp. TMPM | Director | filed 2020 - 2020 |
| Savient Pharmaceuticals INC SVNT | Director | filed 2013 - 2013 |
| Genzyme Corp u4yfvwk$ | President LSD Therapeutics | filed 2008 - 2011 |
| Penwest Pharmaceuticals CO PPCO | Director | filed 2007 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.